Apatinib combined with camrelizumab in advanced acral melanoma patients: An open-label, single-arm phase 2 trial.
Eur J Cancer
; 182: 57-65, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36753834
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Eur J Cancer
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: